Compare CRNX & ALH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | ALH |
|---|---|---|
| Founded | 2008 | 1908 |
| Country | United States | United States |
| Employees | N/A | 3973 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.9B |
| IPO Year | 2018 | N/A |
| Metric | CRNX | ALH |
|---|---|---|
| Price | $41.08 | $25.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $76.75 | $30.88 |
| AVG Volume (30 Days) | ★ 968.2K | 881.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,039,000.00 | N/A |
| Revenue This Year | $720.10 | $7.42 |
| Revenue Next Year | $184.67 | $5.88 |
| P/E Ratio | ★ N/A | $35.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.83 | $18.64 |
| 52 Week High | $57.99 | $27.48 |
| Indicator | CRNX | ALH |
|---|---|---|
| Relative Strength Index (RSI) | 60.96 | 65.20 |
| Support Level | $39.88 | $23.75 |
| Resistance Level | $41.33 | $26.51 |
| Average True Range (ATR) | 1.52 | 0.88 |
| MACD | 0.27 | -0.01 |
| Stochastic Oscillator | 76.34 | 85.14 |
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.